SE8305866L - Heterocykliska foreningar och forfaranden for deras framstellning - Google Patents
Heterocykliska foreningar och forfaranden for deras framstellningInfo
- Publication number
- SE8305866L SE8305866L SE8305866A SE8305866A SE8305866L SE 8305866 L SE8305866 L SE 8305866L SE 8305866 A SE8305866 A SE 8305866A SE 8305866 A SE8305866 A SE 8305866A SE 8305866 L SE8305866 L SE 8305866L
- Authority
- SE
- Sweden
- Prior art keywords
- compounds
- cycloalkyl
- image
- treatment
- procedures
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 229940104915 Alpha 2 adrenoreceptor antagonist Drugs 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010010774 Constipation Diseases 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010021333 Ileus paralytic Diseases 0.000 abstract 1
- 201000005081 Intestinal Pseudo-Obstruction Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 238000005576 amination reaction Methods 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 230000003880 negative regulation of appetite Effects 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 201000007620 paralytic ileus Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8230379 | 1982-10-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8305866D0 SE8305866D0 (sv) | 1983-10-25 |
| SE8305866L true SE8305866L (sv) | 1984-04-26 |
Family
ID=10533819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8305866A SE8305866L (sv) | 1982-10-25 | 1983-10-25 | Heterocykliska foreningar och forfaranden for deras framstellning |
Country Status (18)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8410459D0 (en) * | 1984-04-24 | 1984-05-31 | Glaxo Group Ltd | Chemical compounds |
| DE3579189D1 (de) * | 1984-04-24 | 1990-09-20 | Glaxo Group Ltd | Heterocyclische aminoverbindungen. |
| GB8526210D0 (en) * | 1985-10-23 | 1985-11-27 | Glaxo Group Ltd | Chemical compounds |
| US4769367A (en) * | 1984-04-24 | 1988-09-06 | Glaxo Group Limited | Heterocyclic amino compounds |
| GB8526209D0 (en) * | 1985-10-23 | 1985-11-27 | Glaxo Group Ltd | Chemical process |
| US5225431A (en) * | 1987-10-23 | 1993-07-06 | Burroughs Wellcome Co. | Therapeutic substituted indole compounds and compositions thereof |
| GB8828032D0 (en) * | 1988-12-01 | 1989-01-05 | Glaxo Group Ltd | Medicaments |
| DE10107243A1 (de) * | 2001-02-16 | 2002-08-22 | Bayer Ag | Benzodioxinopyrrole, deren Herstellung und Verwendung |
| US8099200B2 (en) | 2005-09-30 | 2012-01-17 | Coombs Joshua D | Vehicle interface based on the weight distribution of a user |
| US20070074922A1 (en) * | 2005-09-30 | 2007-04-05 | Coombs Joshua D | Vehicle interface based on a shift of the torso of a user |
| US20070074921A1 (en) * | 2005-09-30 | 2007-04-05 | Coombs Joshua D | Vehicle interface based on a shift of the appendages of a user |
| US20090076686A1 (en) * | 2005-09-30 | 2009-03-19 | Jeffrey Schox | Vehicle interface to communicate a safety alert mode command |
| US20070078569A1 (en) * | 2005-09-30 | 2007-04-05 | Jeffrey Schox | Vehicle interface to communicate a safety alert mode command |
-
1983
- 1983-10-24 IL IL70034A patent/IL70034A0/xx unknown
- 1983-10-25 US US06/545,191 patent/US4496579A/en not_active Expired - Fee Related
- 1983-10-25 SE SE8305866A patent/SE8305866L/xx not_active Application Discontinuation
- 1983-10-25 BE BE0/211766A patent/BE898072A/fr not_active IP Right Cessation
- 1983-10-25 GB GB08328468A patent/GB2129795B/en not_active Expired
- 1983-10-25 FI FI833887A patent/FI833887A7/fi not_active Application Discontinuation
- 1983-10-25 NL NL8303673A patent/NL8303673A/nl not_active Application Discontinuation
- 1983-10-25 IT IT8349214A patent/IT1212893B/it active
- 1983-10-25 LU LU85059A patent/LU85059A1/fr unknown
- 1983-10-25 FR FR8316989A patent/FR2534921B1/fr not_active Expired
- 1983-10-25 GR GR72780A patent/GR79405B/el unknown
- 1983-10-25 KR KR1019830005035A patent/KR840006486A/ko not_active Withdrawn
- 1983-10-25 DE DE19833338753 patent/DE3338753A1/de not_active Ceased
- 1983-10-25 ZA ZA837921A patent/ZA837921B/xx unknown
- 1983-10-25 ES ES526738A patent/ES526738A0/es active Granted
- 1983-10-25 JP JP58199871A patent/JPS5998086A/ja active Pending
- 1983-10-25 CH CH5771/83A patent/CH661046A5/fr not_active IP Right Cessation
- 1983-10-25 AU AU20552/83A patent/AU2055283A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| FI833887A7 (fi) | 1984-04-26 |
| FR2534921A1 (fr) | 1984-04-27 |
| SE8305866D0 (sv) | 1983-10-25 |
| CH661046A5 (fr) | 1987-06-30 |
| IT1212893B (it) | 1989-11-30 |
| JPS5998086A (ja) | 1984-06-06 |
| ES8504200A1 (es) | 1985-04-16 |
| BE898072A (fr) | 1984-04-25 |
| FR2534921B1 (fr) | 1987-01-16 |
| GB2129795B (en) | 1986-02-12 |
| IL70034A0 (en) | 1984-01-31 |
| LU85059A1 (fr) | 1985-06-19 |
| GR79405B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-10-22 |
| KR840006486A (ko) | 1984-11-30 |
| ES526738A0 (es) | 1985-04-16 |
| ZA837921B (en) | 1985-04-24 |
| NL8303673A (nl) | 1984-05-16 |
| AU2055283A (en) | 1984-05-03 |
| IT8349214A0 (it) | 1983-10-25 |
| FI833887A0 (fi) | 1983-10-25 |
| GB2129795A (en) | 1984-05-23 |
| GB8328468D0 (en) | 1983-11-23 |
| US4496579A (en) | 1985-01-29 |
| DE3338753A1 (de) | 1984-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8305866L (sv) | Heterocykliska foreningar och forfaranden for deras framstellning | |
| DK623586D0 (da) | Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne | |
| DK158307C (da) | Analogifremgangsmaade til fremstilling af 4-(fenylalkyl)-imidazolderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| KR890002121A (ko) | 신규 벤조피란 유도체, 그의 제조방법 및 이를 함유하는 제약학적 조성물 | |
| ES8207148A1 (es) | Un procedimiento para la preparacion de imidazolilfenilami- dinas. | |
| ATE148990T1 (de) | Ebastin oder ebastin-analoga enthaltende arzneimittel | |
| AU554976B2 (en) | 1-phenyl-2-aminocarbonylindole compounds | |
| IL70099A (en) | Pharmaceutical compositions containing piperidinediones,certain such novel compounds and their preparation | |
| KR870008842A (ko) | N-[2-{[(2- 히드록시 페닐)(페닐)메틸렌]아미노}에틸]아세트아미드 유도체, 그의 제법 및 치료에의 응용 | |
| ES504206A0 (es) | Procedimiento para la preparacion de nuevas 5,10-dihidro -11h-dibenzo b,e 1,4 diazepin-11-onas, sustituidas en posi- cion 5 | |
| JPS56103168A (en) | Thiazole derivative, its preparation, and antihistaminic agent containing the same | |
| HUT42440A (en) | Process for preparing novel indole-carboxamide derivatives and pharmaceutical compositions comprising such compounds | |
| DK156064C (da) | Analogifremgangsmaade til fremstilling af 2,4-(1h,3h)-quinazolindionderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| CS402491A3 (en) | Heterocyclic amino compounds, process for their preparation andpharmaceutical compositions containing thereof | |
| AU678320B2 (en) | N-p-Halobenzoylmethyl derivatives of 4-(p-fluorophenyl)-3-((3,4-(methylene-dioxy)phenoxy)methyl) piperidine | |
| AU564457B2 (en) | Phlorophenone derivatives | |
| ATE8786T1 (de) | Indolobenzoxazinderivate, ihre salze, verfahren zur herstellung, ihre verwendung als arzneimittel und sie enthaltende zusammensetzungen. | |
| US5087627A (en) | Agent for treatment of disorders of the cerebro-neural transmission system | |
| IL72647A0 (en) | Indole derivatives,their preparation and pharmaceutical compositions containing them | |
| HUT36469A (en) | Process for producing 2-/n-pyrrolidino/-3-isobuthyloxy-n-/substituted phenyl/-n-benzyl-propyl-amines and acid additional salts thereof | |
| SU1355128A3 (ru) | Способ получени пиперазинсодержащих производных алкилтиола или алкилтиокарбамата или их солей | |
| ES8305329A1 (es) | Procedimiento para la preparacion de 4-(3-trifluormetilfenil)-1,2,3,6-tetrahidropiridinas. | |
| ES482581A1 (es) | Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2) sustituidas. | |
| ZA881383B (en) | 2-(2,3-dihydro-2-oxo-3-benzofuranyl)acetic acid derivatives,processes for preparing them and the pharmaceutical compositions which contain them | |
| SE8207294D0 (sv) | 1,4-tiazankarboxylsyraderivat, deras framstellning och anvendning och kompositioner vari dessa derivat ingar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8305866-9 Effective date: 19851011 |